Department Of Pediatric Oncology
Investigator
Luca Szalontay, MD
Phone
212-305-9770
Email
ls3399@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By This Investigator:
Condition Study Title
Pediatric Solid Tumors [ CLOSED ] A study in children, adolescents, and young adults recurrent or refractory solid tumors using study drug nivolumab
Cancer [ CLOSED ] Study of New Drug with Radiation Therapy in Children with Diffuse Intrinsic Pontine Gliomas (DIPG) Brain Stem Cancer
Cancer [ CLOSED ] Study of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Subjects with Central Nervous System Malignancies
Solid Tumors [ CLOSED ] Study of VX15/2508 in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years)
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21)
Leukemia [ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (18 to 21 years old)
Childhood Leukemia [ CLOSED ] MLN4924 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (1 month to 17 years old)
Cancer [ CLOSED ] Study of Flotetuzumab for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Childhood Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML)
Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML)